According to Omega Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6840. At the end of 2024 the company had a P/S ratio of 8.99.
Year | P/S ratio | Change |
---|---|---|
2024 | 8.99 | -83.23% |
2023 | 53.6 | -59.46% |
2022 | 132 | -96.48% |
2021 | > 1000 |